Related references
Note: Only part of the references are listed.Extracellular nanovesicles for packaging of CRISPR-Cas9 protein and sgRNA to induce therapeutic exon skipping
Peter Gee et al.
NATURE COMMUNICATIONS (2020)
beta T87Q-Globin Gene Therapy Reduces Sickle Hemoglobin Production, Allowing for Ex Vivo Anti-sickling Activity in Human Erythroid Cells
Selami Demirci et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2020)
CRISPResso2 provides accurate and rapid genome editing sequence analysis
Kendell Clement et al.
NATURE BIOTECHNOLOGY (2019)
Bone marrow characterization in sickle cell disease: inflammation and stress erythropoiesis lead to suboptimal CD34 recovery
Alexis Leonard et al.
BRITISH JOURNAL OF HAEMATOLOGY (2019)
Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates
Zulema Romero et al.
MOLECULAR THERAPY (2019)
Highly efficient editing of the β-globin gene in patient-derived hematopoietic stem and progenitor cells to treat sickle cell disease
So Hyun Park et al.
NUCLEIC ACIDS RESEARCH (2019)
CRISPR-Cas9 fusion to dominant-negative 53BP1 enhances HDR and inhibits NHEJ specifically at Cas9 target sites
Rajeswari Jayavaradhan et al.
NATURE COMMUNICATIONS (2019)
High-Efficiency Lentiviral Transduction of Human CD34+ Cells in High-Density Culture with Poloxamer and Prostaglandin E2
Naoya Uchida et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2019)
In Vivo Outcome of Homology-Directed Repair at the HBB Gene in HSC Using Alternative Donor Template Delivery Methods
Sowmya Pattabhi et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2019)
Development of a forward-oriented therapeutic lentiviral vector for hemoglobin disorders
Naoya Uchida et al.
NATURE COMMUNICATIONS (2019)
Preclinical Evaluation for Engraftment of Gene-Edited CD34+Cells with a Sickle Cell Disease Mutation in a Rhesus Transplantation Model
Naoya Uchida et al.
BLOOD (2019)
Optimization of CRISPR/Cas9 Delivery to Human Hematopoietic Stem and Progenitor Cells for Therapeutic Genomic Rearrangements
Annalisa Lattanzi et al.
MOLECULAR THERAPY (2019)
Genome editing in primary cells and in vivo using viral-derived Nanoblades loaded with Cas9-sgRNA ribonucleoproteins
Philippe E. Mangeot et al.
NATURE COMMUNICATIONS (2019)
Inhibition of 53BP1 favors homology-dependent DNA repair and increases CRISPR-Cas9 genome-editing efficiency
Marella D. Canny et al.
NATURE BIOTECHNOLOGY (2018)
Characterization of Gene Alterations following Editing of the β-Globin Gene Locus in Hematopoietic Stem/Progenitor Cells
Joseph Long et al.
MOLECULAR THERAPY (2018)
CRISPR/Cas9 genome editing in human hematopoietic stem cells
Rasmus O. Bak et al.
NATURE PROTOCOLS (2018)
VSV-G-Enveloped Vesicles for Traceless Delivery of CRISPR-Cas9
Claudia Montagna et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2018)
Serum-free Erythroid Differentiation for Efficient Genetic Modification and High-Level Adult Hemoglobin Production
Naoya Uchida et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2018)
Efficient Generation of β-Globin-Expressing Erythroid Cells Using Stromal Cell-Derived Induced Pluripotent Stem Cells from Patients with Sickle Cell Disease
Naoya Uchida et al.
STEM CELLS (2017)
Gene Therapy in a Patient with Sickle Cell Disease
Jean-Antoine Ribeil et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Integrase-Deficient Lentiviral Vector as an All-in-One Platform for Highly Efficient CRISPR/Cas9-Mediated Gene Editing
Pavel I. Ortinski et al.
MOLECULAR THERAPY-METHODS & CLINICAL DEVELOPMENT (2017)
CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells
Daniel P. Dever et al.
NATURE (2016)
Selection-free genome editing of the sickle mutation in human adult hematopoietic stem/progenitor cells
Mark A. DeWitt et al.
SCIENCE TRANSLATIONAL MEDICINE (2016)
Correction of the sickle cell disease mutation in human hematopoietic stem/progenitor cells
Megan D. Hoban et al.
BLOOD (2015)
Highly efficient RNA-guided genome editing in human cells via delivery of purified Cas9 ribonucleoproteins
Sojung Kim et al.
GENOME RESEARCH (2014)
TRIM5α Variations Influence Transduction Efficiency With Lentiviral Vectors in Both Human and Rhesus CD34+Cells In Vitro and In Vivo
Molly E. Evans et al.
MOLECULAR THERAPY (2014)
Improved vectors and genome-wide libraries for CRISPR screening
Neville E. Sanjana et al.
NATURE METHODS (2014)
A guide to genome engineering with programmable nucleases
Hyongbum Kim et al.
NATURE REVIEWS GENETICS (2014)
DNA targeting specificity of RNA-guided Cas9 nucleases
Patrick D. Hsu et al.
NATURE BIOTECHNOLOGY (2013)
Efficient genome editing in zebrafish using a CRISPR-Cas system
Woong Y. Hwang et al.
NATURE BIOTECHNOLOGY (2013)
High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells
Yanfang Fu et al.
NATURE BIOTECHNOLOGY (2013)
Establishment of Immortalized Human Erythroid Progenitor Cell Lines Able to Produce Enucleated Red Blood Cells
Ryo Kurita et al.
PLOS ONE (2013)
Multiplex Genome Engineering Using CRISPR/Cas Systems
Le Cong et al.
SCIENCE (2013)
Integration-specific In Vitro Evaluation of Lentivirally Transduced Rhesus CD34+ Cells Correlates With In Vivo Vector Copy Number
Naoya Uchida et al.
MOLECULAR THERAPY-NUCLEIC ACIDS (2013)
High-efficiency Transduction of Rhesus Hematopoietic Repopulating Cells by a Modified HIV1-based Lentiviral Vector
Naoya Uchida et al.
MOLECULAR THERAPY (2012)
Optimal conditions for lentiviral transduction of engrafting human CD34+ cells
N. Uchida et al.
GENE THERAPY (2011)
Transfusion independence and HMGA2 activation after gene therapy of human β-thalassaemia
Marina Cavazzana-Calvo et al.
NATURE (2010)
Stem-Cell Gene Therapy for the Wiskott-Aldrich Syndrome
Kaan Boztug et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
CRISPR/Cas, the Immune System of Bacteria and Archaea
Philippe Horvath et al.
SCIENCE (2010)
Development of a Human Immunodeficiency Virus Type 1-Based Lentiviral Vector That Allows Efficient Transduction of both Human and Rhesus Blood Cells
Naoya Uchida et al.
JOURNAL OF VIROLOGY (2009)
Integration-deficient Lentiviral Vectors: A Slow Coming of Age
Klaus Wanisch et al.
MOLECULAR THERAPY (2009)
Gene Therapy for Immunodeficiency Due to Adenosine Deaminase Deficiency.
Alessandro Aiuti et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Leukemogenesis of b2a2-type p210 BCR/ABL in a Bone Marrow Transplantation Mouse Model Using a Lentiviral Vector
Naoya Uchida et al.
JOURNAL OF NIPPON MEDICAL SCHOOL (2009)
Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1
Salima Hacein-Bey-Abina et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
Gene editing in human stem cells using zinc finger nucleases and integrase-defective lentiviral vector delivery
Angelo Lombardo et al.
NATURE BIOTECHNOLOGY (2007)
LMO2-associated clonal T cell proliferation in two patients after gene therapy for SCID-X1
S Hacein-Bey-Abina et al.
SCIENCE (2003)
A serious adverse event after successful gene therapy for X-linked severe combined immunodeficiency
S Hacein-Bey-Abina et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Correction of ADA-SCID by stem cell gene therapy combined with nonmyeloablative conditioning
A Aiuti et al.
SCIENCE (2002)
Comparison of various envelope proteins for their ability to pseudotype lentiviral vectors and transduce primitive hematopoietic cells from human blood
H Hanawa et al.
MOLECULAR THERAPY (2002)
Efficient expression of foreign genes in human CD34+ hematopoietic precursor cells using electroporation
MH Wu et al.
GENE THERAPY (2001)
High efficiency electroporation of human umbilical cord blood CD34(+) hematopoietic precursor cells
MH Wu et al.
STEM CELLS (2001)
High-level transgene expression in primary human T lymphocytes and adult bone marrow CD34+ cells via electroporation-mediated gene delivery
VFI Van Tendeloo et al.
GENE THERAPY (2000)
Gene therapy of human severe combined immunodeficiency (SCID)-X1 disease
M Cavazzana-Calvo et al.
SCIENCE (2000)
Share Paper
